Novartis Finds Defense in Alcon When Bernstein Research upgraded Novartis NVS to outperform in May, the firm dubbed the stock one of the three best-positioned drugmakers to withstand future patent expirations.Novartis' plan to acquire a majority stake in fellow Swiss...
Novartis Finds Defense in Alcon When Bernstein Research upgraded Novartis NVS to outperform in May, the firm dubbed the stock one of the three best-positioned drugmakers to withstand future patent expirations.Novartis' plan to acquire a majority stake in fellow Swiss...
Novartis Finds Defense in Alcon When Bernstein Research upgraded Novartis NVS The wave of patent expiry, pricing pressures as well as higher regulatory hurdles in the U.S.have already begun to plague Big Pharma companies.
Refocusing and restructuring initiatives have...
Teva Provides Update on FORTE Trial JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.(NASDAQ: TEVA - News) today announced top-line results from a Phase III study designed to assess the efficacy, safety and tolerability of glatiramer acetate (GA) 40mg as...
Teva Provides Update on FORTE Trial Author : TEVA-PHARMACEUTICAL Category : Press Release News Alerts by Email click here ) News | Home JERUSALEM - (Business Wire) Teva Pharmaceutical Industries Ltd.(NASDAQ: TEVA) today announced top-line results from a Phase III study...
Teva Provides Update on FORTE Trial JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.(NASDAQ: TEVA - News) today announced top-line results from a Phase III study designed to assess the efficacy, safety and tolerability of glatiramer acetate (GA) 40mg as...
Teva Provides Update on Generic Seroquel Liti JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.(Nasdaq: TEVA) announced today that the U.S.
District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug...
Teva Provides Update on Generic Seroquel(R) Litigation JERUSALEM - (Business Wire) Teva Pharmaceutical Industries Ltd.(Nasdaq: TEVA) announced today that the U.S.
District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug...
Teva Provides Update on Generic Seroquel(R) Litigation JERUSALEM -- (Business Wire) Teva Pharmaceutical Industries Ltd.(Nasdaq: TEVA) announced today that the U.S.
District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug...
Teva Receives First U.S. Approval for Generic Risperdal(R) Tablets; Commences Commercial Launch JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.(NASDAQ:TEVA - News) announced today that the U.S.
Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA)...
Teva Receives First U.S. Approval for Generic Risperdal(R) Tablets; Commences Commercial Launch JERUSALEM, Israel -- (Business Wire) Teva Pharmaceutical Industries Ltd.(NASDAQ:TEVA) announced today that the U.S.
Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to...
Teva Receives First U.S. Approval for Generic Risperdal(R) Tablets; Commences Commercial Launch Author : TEVA-PHARMACEUTICAL Category : Press Release News Alerts by Email click here ) News | Home JERUSALEM, Israel - (Business Wire) Teva Pharmaceutical Industries Ltd.(NASDAQ:TEVA) announced today that the U.S.
Food and Drug...
Teva Receives First U.S. Approval for Generic Risperdal(R) Tablets; Commences Commercial Launch JERUSALEM, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.(NASDAQ:TEVA - News) announced today that the U.S.
Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA)...
Teva Announces Tentative Approval of Generic Diovan(R) Tablets JERUSALEM--(HSMN NewsFeed)--Teva Pharmaceutical Industries Ltd.(Nasdaq: TEVA ) announced today that the U.S.
Food and Drug Administration has granted tentative approval for the Companys Abbreviated New Drug Application (ANDA) to market...
Management of Herpes Simplex Infections Reviewed Describe the epidemiology of herpes simplex virus infections.Identify recommend medication regimens for the acute and suppressive treatment of herpes simplex virus infections.
Authors and Disclosures Laurie Barclay, MD Disclosure:...
Teva Announces Launch Of Generic Wellbutrin XL(R) Tablets, 150 Mg (NASDAQ: TEVA) announced that it has begun commercially shipping Bupropion Hydrochloride Extended-Release Tablets, 150 mg, the generic version of Biovail Corporation's antidepressant Wellbutrin XL Tablets, pursuant to its March 2007...
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg JERUSALEM, Israel--(HSMN NewsFeed)--Teva Pharmaceutical Industries Ltd.(NASDAQ: TEVA ) announced today that it has begun commercially shipping Bupropion Hydrochloride Extended-Release Tablets, 150 mg, the generic version of Biovail...
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg Teva Pharmaceutical Industries Ltd.(NASDAQ: TEVA) announced today that it has begun commercially shipping Bupropion Hydrochloride Extended-Release Tablets, 150 mg, the generic version of Biovail Corporations antidepressant Wellbutrin XL...
Novartis Q1 earnings beat forecasts, confirms outlook UPDATE (Updating with details on outlook, EBIT, segment performance, restructuring, Alcon) ZURICH (Thomson Financial) - Novartis AG.said first quarter net profit from continuing operations rose to $2.308 billion from $2.092 billion in the same...
